All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @drsalaswhalen on Instagram · 60s|Watch on Instagram
Full video transcriptClick to expand

Auto-generated transcript of @drsalaswhalen's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00What comes to your mind when you hear the word testosterone?
  2. 0:04Is it this or
  3. 0:06this and
  4. 0:08Who can blame you if you google testosterone?
  5. 0:11These are the images that pop out with it
  6. 0:15But it's time that we see testosterone as this and also as this
  7. 0:31and
  8. 0:32like this
  9. 0:35We women get all the same benefits that you would think men get from testosterone
  10. 0:42All the same
  11. 0:43So it's time that we as women and
  12. 0:47doctors and health care providers
  13. 0:50Change the way that we think of testosterone because testosterone is also a female hormone

@drsalaswhalen's menopause HRT claims need more context

Rocio Salas-Whalen, MD.

Instagram creator

321.2K viewsView on Instagram

Quick answer

Dr. Salas-Whalen, a New York-based endocrinologist, argues that testosterone is a female hormone and that women receive equivalent benefits from it as men do. The claim is grounded in real physiology but overstates the current evidence base, which strongly supports testosterone for female sexual dysfunction but shows mixed or preliminary results for other endpoints like mood, cognition, and body composition. No testosterone formulation is currently FDA-approved for women in the U.S., meaning all female prescribing occurs off-label.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @drsalaswhalen's menopause HRT claims need more context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

@drsalaswhalen's menopause HRT claims need more context should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@drsalaswhalen's menopause HRT claims need more context" from Rocio Salas-Whalen, MD.. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Dr.

The reason this review is not generic is the source wording and the canonical claim label "trt to see me as a patient in my new york city private practice." In this clip, the useful excerpt is: "What comes to your mind when you hear the word testosterone?" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The 2019 Global Consensus Position Statement (Wierman et al.
People who land here are usually comparing the Testosterone claim with menopause, menopauserelief, and menopausesupport.
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Dr.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Dr. Salas-Whalen, a New York-based endocrinologist, argues that testosterone is a female hormone and that women receive equivalent benefits from it as men do. The claim is grounded in real physiology but overstates the current evidence base, which strongly supports testosterone for female sexual dysfunction but shows mixed or preliminary results for other endpoints like mood, cognition, and body composition. No testosterone formulation is currently FDA-approved for women in the U.S., meaning all female prescribing occurs off-label.
  • Testosterone is physiologically female: premenopausal women typically circulate 15 to 70 ng/dL, produced by the ovaries and adrenal glands.
  • The 2019 Global Consensus Position Statement (Wierman et al.) gives the strongest evidence rating to testosterone for hypoactive sexual desire disorder in postmenopausal women.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Testosterone is physiologically female: premenopausal women typically circulate 15 to 70 ng/dL, produced by the ovaries and adrenal glands.
  • The 2019 Global Consensus Position Statement (Wierman et al.) gives the strongest evidence rating to testosterone for hypoactive sexual desire disorder in postmenopausal women.
  • Evidence for testosterone improving mood, cognition, and body composition in women is preliminary and inconsistent, per Papalia et al., 2021, Journal of Sexual Medicine.
  • No testosterone product is currently FDA-approved for women in the U.S. All female prescribing is off-label, which increases variability in dosing and monitoring.
  • The American College of Obstetricians and Gynecologists supports individualized assessment before initiating testosterone therapy in women, not population-wide prescribing.
  • Clinician surveys show most women are never offered or counseled about testosterone therapy, even when symptoms suggest it could be appropriate, per Davis et al., 2019.
  • Conflating female therapeutic testosterone use with male high-dose protocols is a category error that contributes to both over-caution and, in some cases, inappropriate dosing.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @drsalaswhalen actually say?

Dr. Salas-Whalen made one central argument: testosterone is not just a male hormone, and women deserve to benefit from it just as much as men do. Her exact framing was that "testosterone is also a female hormone" and that "we women get all the same benefits that you would think men get from testosterone."

The video uses a contrast device, showing culturally male images of testosterone versus images presumably meant to represent women, to challenge the reflex association between testosterone and masculinity. The implicit argument is that medical culture and public perception have both underserved women by treating testosterone as off-limits or irrelevant to female physiology. That is a reasonable argument, and it is not without scientific support. But the all-or-nothing claim that women get "all the same benefits" from testosterone deserves more scrutiny than a 60-second reel can provide.

Does the science back this up?

On the foundational biology, yes. Testosterone is genuinely a female hormone. Ovaries and adrenal glands produce it, circulating levels in premenopausal women typically range from 15 to 70 ng/dL, and it plays documented roles in libido, bone density, muscle mass, and mood. This is not fringe science.

The Global Consensus Position Statement on testosterone therapy for women, published by Wierman and colleagues in 2019 across multiple major endocrinology journals, concluded that there is strong evidence for testosterone improving hypoactive sexual desire disorder (HSDD) in postmenopausal women. That is not a minor finding. However, the same consensus statement was careful to note that evidence for broader benefits like cognitive function, mood, energy, and body composition is still inconsistent or preliminary. So "all the same benefits" is doing a lot of work in that sentence. The evidence base is not uniform across outcomes.

What did they get wrong (or right)?

Give Dr. Salas-Whalen credit for the core claim: testosterone is a female hormone. That is accurate and worth saying loudly, because clinician surveys consistently show that most women are never counseled about testosterone therapy even when it might be appropriate. Davis and colleagues (2019, Journal of Clinical Endocrinology and Metabolism) found that awareness and prescribing of testosterone for women remains low relative to what evidence supports.

Where the framing gets slippery is the phrase "all the same benefits." Men seeking testosterone therapy are often targeting libido, muscle, energy, and mood. For women, the evidence is strongest for sexual function and weakest for the other domains. Papalia and colleagues (2021, Journal of Sexual Medicine) confirmed libido benefits but found mixed results for mood and cognition. Saying women get all the same benefits without that nuance risks setting expectations that the data does not yet fully support, and it may push women toward higher-dose protocols with less-established safety profiles.

What should you actually know?

Testosterone therapy for women is legitimate medicine. It is not the same as the high-dose, muscle-focused use associated with male bodybuilding culture, and conflating the two has genuinely harmed women by making both patients and doctors uncomfortable with a therapy that, at appropriate doses, has a real evidence base.

The practical reality: no testosterone product is currently FDA-approved for women in the United States. Clinicians who prescribe it are doing so off-label, typically using male-formulated products at fractions of the standard male dose or compounded preparations. That is not inherently wrong, but it means patients are working in a space with less regulatory oversight and more clinical variability. The 2019 Global Consensus Statement remains the best evidence-based framework for guiding these decisions, and it recommends individualized assessment, not a one-size-fits-all approach. If you are a woman curious about testosterone, a conversation with a board-certified endocrinologist or gynecologist is the right starting point, not an Instagram reel.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Rocio Salas-Whalen, MD. · Instagram creator

321.2K views on this video

To see me as a patient in my New York City private practice, please contact my office. . ☎️ 212-722-3636 📧 reception@nyendocrinology.com 💻 www.nyendocrinology.com. The content of this page is for ed

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about testosterone?

Testosterone is physiologically female: premenopausal women typically circulate 15 to 70 ng/dL, produced by the ovaries and adrenal glands.

What does the video say about the 2019 global consensus position statement (wierman et al.) gives?

The 2019 Global Consensus Position Statement (Wierman et al.) gives the strongest evidence rating to testosterone for hypoactive sexual desire disorder in postmenopausal women.

What does the video say about evidence for testosterone improving mood, cognition,?

Evidence for testosterone improving mood, cognition, and body composition in women is preliminary and inconsistent, per Papalia et al., 2021, Journal of Sexual Medicine.

What does the video say about no testosterone product?

No testosterone product is currently FDA-approved for women in the U.S. All female prescribing is off-label, which increases variability in dosing and monitoring.

What does the video say about the american college of obstetricians?

The American College of Obstetricians and Gynecologists supports individualized assessment before initiating testosterone therapy in women, not population-wide prescribing.

What does the video say about clinician surveys show most women?

Clinician surveys show most women are never offered or counseled about testosterone therapy, even when symptoms suggest it could be appropriate, per Davis et al., 2019.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Rocio Salas-Whalen, MD., not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.